Atypical Antipsychotics Induced Metabolic Syndrome
The use of atypical antipsychotics in patients with schizophrenia is tightly related to the metabolic abnormalities like weight gain, diabetes, dyslipidemia and/or hypertension. Beside of having unique receptor binding features, their heterogeneous receptor binding properties ara also involved in th...
| Main Authors: | , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Psikiyatride Güncel Yaklaşımlar
2015-03-01
|
| 丛编: | Psikiyatride Güncel Yaklaşımlar |
| 主题: | |
| 在线阅读: | http://www.cappsy.org/archives/vol7/no1/cap_07_01_07.pdf |